Michael Donegan
2015
In 2015, Michael Donegan earned a total compensation of $706.8K as Vice President - Finance at TherapeuticsMD, a 107% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $36,000 |
|---|---|
| Option Awards | $480,553 |
| Salary | $180,000 |
| Other | $10,218 |
| Total | $706,771 |
Donegan received $480.6K in option awards, accounting for 68% of the total pay in 2015.
Donegan also received $36K in non-equity incentive plan, $180K in salary and $10.2K in other compensation.
Rankings
In 2015, Michael Donegan's compensation ranked 9,485th out of 13,638 executives tracked by ExecPay. In other words, Donegan earned more than 30.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,485 out of 13,638 | 31st |
Division Manufacturing | 3,618 out of 5,190 | 30th |
Major group Chemicals And Allied Products | 1,319 out of 1,854 | 29th |
Industry group Drugs | 1,077 out of 1,528 | 30th |
Industry Pharmaceutical Preparations | 842 out of 1,182 | 29th |
Source: SEC filing on April 25, 2017.
Donegan's colleagues
We found four more compensation records of executives who worked with Michael Donegan at TherapeuticsMD in 2015.